Expand ADVM Menu
ADVM MENU

ADVM Latest Press Releases

-- December 9, 2025 --

Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition PRNewswire 8:29 AM

-- December 1, 2025 --

Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly Globe Newswire 7:00 AM

-- November 19, 2025 --

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 6:18 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP PRNewswire 2:10 PM

-- November 18, 2025 --

Halper Sadeh LLC Encourages CMA, ADVM, HOUS Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 7:15 PM

-- October 27, 2025 --

HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PRNewswire 1:01 PM
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders Business Wire 9:40 AM

-- October 25, 2025 --

Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM Business Wire 11:41 AM

-- October 24, 2025 --

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) PRNewswire 5:30 PM
Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 2:57 PM
Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders PRNewswire 1:47 PM
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders Globe Newswire 9:39 AM
Lilly to Acquire Adverum Biotechnologies PRNewswire 8:30 AM

-- September 24, 2025 --

Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream Globe Newswire 7:00 AM

-- September 23, 2025 --

Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream Globe Newswire 7:00 AM

-- September 22, 2025 --

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration Globe Newswire 8:00 AM

-- September 5, 2025 --

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- August 20, 2025 --

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes